搜尋結果
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 1 小時前Johnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering price on Friday, ...
In 2024, many Y Combinator startups only want tiny seed rounds — but there’s a catch | TechCrunch
TechCrunch· 2 小時前When Bowery Capital general partner Loren Straub started talking to a startup from the latest Y Combinator accelerator batch ...
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 6 小時前Patients with musculoskeletal conditions who like to stay in their pajamas received some ...
‘The Age of Reconstruction’ Review: A Global Emancipation
The Wall Street Journal· 7 小時前Historians generally treat Reconstruction as an era whose aspiration, drama and importance are ...
Geron surges after winning first US FDA approval for blood disorder drug
Reuters· 7 小時前, opens new tab surged more than 30% on Friday, a day after the company gained its first ...
Gene therapy improves deaf children's hearing
China Daily· 8 小時前All five children taking part in a Shanghai-led clinical trial of a gene therapy to treat congenital ...
The rise of Hong Kong's booming bakery scene
Dimsum Daily· 8 小時前The numbers speak for themselves: as of late 2023, Hong Kong was home to a staggering 497 licensed bakeries, a figure that ...
Expert: China and Brazil can cooperate in many fields
China Daily· 11 小時前... is a critical initiative for different countries to develop partnerships with< ... ...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters· 11 小時前, opens new tab top-selling arthritis drug Humira has held onto more than 80% of patients after ...
The quiet Apple executive behind Apple's AI strategy
CNBC· 11 小時前... Apple to deliver an impressive slate of AI products and services. In interviews with ... ...